HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical effects of recombinant versus urinary gonadotropins in ovulation induction].

AbstractOBJECTIVE:
To present an overview of trials and discussion focused on the clinical characteristics of recombinant gonadotropins compared with urinary ones in ovulation induction.
SUBJECT:
Review article.
SETTING:
Sanatorium Pronatal, Prague.
SUBJECT AND METHOD:
The subject of the study is to compare the clinical characteristics of recombinant gonadotropins versus urinary ones focused on the daily dose of FSH achieving FSH threshold and the risk of multifollicular development in ovulation induction before intrauterine insemination, number of follicles and oocytes, the risk of ovarian hyperstimulation syndrome (OHSS), total consumption of FSH, cost effectiveness and expected pregnancy rate during in vitro fertilization technique. The method is a MEDLINE research of articles from 1994 to 2010.
CONCLUSIONS:
Data demonstrates that recombinant FSH (rFSH) offers higher ovarian response, less consumption of gonadotropins, lower risk of complications (multiple pregnancy and OHSS) compared with urinary FSH (uFSH). Expected pregnancy rate is probably comparable.
AuthorsR Streda, D Koryntová, T Mardesic, V Sobotka, J Sobotková
JournalCeska gynekologie (Ceska Gynekol) Vol. 76 Issue 2 Pg. 108-13 (Apr 2011) ISSN: 1210-7832 [Print] Czech Republic
Vernacular TitleProkázané klinické ucinky rekombinantních gonadotropinů v porovnání s urinárními v indukci ovulace.
PMID21649993 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Recombinant Proteins
  • Follicle Stimulating Hormone
Topics
  • Female
  • Follicle Stimulating Hormone (administration & dosage, urine)
  • Humans
  • Ovulation Induction (methods)
  • Pregnancy
  • Recombinant Proteins (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: